Purpose: The diagnosis of chronic bone and joint infections, particularly in patients with implants, can be a difficult task. Among the clinical and laboratory tests proposed for the diagnosis of infection, 99mTc HMPOA labelled leukocyte scintigraphy is one of the least invasive examinations available. We evaluated its efficacy in terms of reliability.

Material and methods: Ninety patients with suspected bone and joint infections were included in this study: 53% men and 47% women. Mean age was 56.6 years and 80% had osteosynthesis implants. Mean duration of clinical signs before scintigraphy was 6.5 months. The suspected site was the hip in 49%, the knee in 28% and another in 23%. Physical examination (local aspect, temperature) and laboratory tests (differential count, platelets, CRP, ESR) as well as standard radiographs were performed in addition to labelled scintigraphy. These patients were operated and bone samples were taken for bacteriology studies to confirm or infirm the presence of infection. In this series, 73% of the patients were found to have a real infection (73% staphylococcal, 17% multiple germs, 20% other).

Results: The following variables were included in the multivariate analysis: fever, standard radiographs, polynuclear neutrophil count, CRP, ESR, leukocyte-labelled scintigraphy. Sensitivity (Se), specificity (Sp), and odds ratio (OR) were determined. The multivariate analysis showed: fever (Se=0.48; Sp=0.59; OR=1.3); abnormal radiograph (Se=0.71; Sp=0.62; OR=4; p=0.02); polynuclear neutrophil count (OR=1; p=0.19); CRP (OR=1.02; p=0.06); ESR (OR=1.03; p=0.04); leukocyte-labelled scintigraphy (Se=0.71; Sp=0.82; OR=11.6; p< 0.001).

Discussion and conclusion: These findings demonstrate the efficacy of 99mTc HMPOA-labelled leukocyte scintigraphy in terms of reliability for the diagnosis of chronic bone infection compared with other clinical (fever), laboratory (ESR, CRP), and radiographic indicators.

Purpose: Patients hospitalized for osteomyelitis due to multi-resistant strains are often given prolonged parenteral antibiotics. Ambulatory parenteral antibiotic therapy is an alternative allowing outpatient care. The purpose of this study is to assess tolerance, cost and efficacy of this type of treatment.

Material and methods: Thirty-nine patients followed for osteomyelitis were included in this study. These patients were given antibiotics in a continuous infusion using a portable diffuser connected to an implanted chamber. Mean duration of treatment was four months, range 1.5–12 months. The follow-up team included the primary care physician, an infectious diseases specialist, and a nurse with special training in prolonged ambulatory antibiotic treatments. Results of weekly blood tests were transmitted to the referral hospital physician. Adverse effects and cost of prolonged ambulatory antibiotic therapy were recorded. Cost included costs for nurses, physical therapists, and physicians as well as drugs, supplies and laboratory tests. The cost of hospitalisation was determined on the basis of the standard cost for one day of hospitalisation in France.

Results: There were three cases of thrombophlebitis and one case of allergic reaction, both required re-hospitalisation. Cure was achieved in 93% of the patients. Mean follow-up since cure with discontinuation of the antibiotics was 18 months (14–22). Home care was possible in 100% of the patients and 23% of the patients were able to resume their occupational activity; 25% resumed their schooling. Self-administered schemes were possible in 23% of the patients. Compared with conventional hospitalisation, ambulatory parenteral antibiotic therapy enabled a cost savings of 1352 euros per patient.

Discussion: These results demonstrate that ambulatory antibiotic therapy is a very good alternative to classical hospitalisation enabling low morbidity, early resumption of social activities without loss of efficacy.

Purpose: A significant increase in serum cobalt level has been reported after metal-on-metal total hip arthroplasty with wide individual variability related to activity level, mechanical conditions of the implant, and urinary elimination of cobalt. We studied serum cobalt levels over time to further analyse these factors.

Material and methods: The Metazul® prosthesis was implanted in 119 patients (72 men and 47 women, 12 bilateral implantations) (131 implants). We selected 50 patients (27 men and 23 women, mean age 53 years) who had two blood samples after the procedure allowing an assessment of the serum cobalt kinetics. Other chromium-cobalt implants, vitamin B12 intake, renal failure, or haematological disorders were recorded. An activity questionnaire was filled out by the patients at the time of the blood sample. Samples were drawn with a special kit to avoid metal contamination. The detection limit was 1 nmol/L (0.06 μg/L) with direct electrothermic atomic spectrometric absorption.

Results: In the overall series, serum cobalt level was 44 nmol/L for a physiological level in a control population of 4.28 nmol/L. The difference was significant (p < 0.0001) between the levels observed before surgery and after 18 months implantation. There was no significant correlation with the indication for arthroplasty, presence of dislocation or subdislocation, functional outcome or radiographic findings. Activity level the week before sampling did not influence the results. For the 50 cases evaluated longitudinally, four groups of patients could be identified. The first group (29 patients) had a serum cobalt level below 50 nmol/L over the entire study period. The second group (nine patients) had a level greater than 50 nmol/L followed by a decline ending with a final level below 50 nmol/L. In the third group (six patients) serum cobalt was greater than 50 nmol/L with no trend to a decline. In the fourth group (six patients) the cobalt levels were very high (greater than 150 nmol/L).

Discussion: The six patients in the fourth group were very particular. There were three patients with secondary bilateral implants with a late peak in serum cobalt, one with an impingement on the acetabular rim, one with renal failure, and one who had a very high level of physical activity. The first group had what appears to be a favourable course, similar to the second group where a stabilisation phenomenon could be operating. An explanation in the third group is difficult but could involve a third segment abrasion phenomenon.

Conclusion: Longitudinal analysis of serum cobalt levels provides more information than point measures in patients with metal-on-metal arthroplasties. Intercurrent mechanical phenomena can be detected; unexpected behaviour of the metal-on-metal junction can be suspected in certain patients.